Allianz’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Allianz's ELV Position: Q2 2026 in Review
Allianz increased its Elevance Health (ELV) stake by 62% in Q2 2026, buying an estimated $3.17M and bringing the position to 22,403 shares worth $8.66M. The position accounts for 0.09% of the portfolio, ranked #137.
Allianz first reported a position in ELV in Q1 2024 and has held it in 10 quarters since. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Allianz held 22,403 shares of Elevance Health worth $8.66M as of Q2 2026.
- Allianz bought 8,546 Elevance Health shares in Q2 2026, an estimated $3.17M.
- Elevance Health made up 0.09% of Allianz's portfolio in Q2 2026, its #137 holding.
- Allianz first reported a position in Elevance Health in Q1 2024 and has held it in 10 quarters since.
- 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.